AstraZeneca (ADR) (AZN)
Develops oncology-led medicines spanning rare diseases, cardiovascular care, metabolism, respiratory disease, and immunology.
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 105.83% | 820.47M ADS | |
|---|---|---|---|
| 1,521 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.00% | 19.3K ADS | |
| 1 holder · as of Sep 11, 2026 | |||
| Adds to | 105.83% | ||
775.27M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2024 annual report; nothing newer is on file here.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 105.83%; nothing is left for Other.
13F, as of Jun 30, 2026
1,521 holders · 820.47M shares · 283 new positions · 799 increased · 482 reduced · 132 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Investor AB | 51.59M | 6.65% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 45.39M | 5.85% | +346.0K | Aug 13, 2026 |
| Capital International Investors | 34.58M | 4.46% | +183.1K | Aug 12, 2026 |
| Norges Bank | 33.86M | 4.37% | +33.86Mnew | Aug 12, 2026 |
| Capital World Investors | 30.08M | 3.88% | +1.81M | Aug 12, 2026 |
| FMR LLC | 28.90M | 3.73% | −706.5K | Aug 13, 2026 |
| Wellington Management Group LLP | 28.54M | 3.68% | +4.79M | Aug 14, 2026 |
| Legal & General Group PLC | 25.75M | 3.32% | −99.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.60% | 13G | Apr 23, 2025 | |
| Vanguard Capital Management | 5.02% | 77.97M | 13G | Apr 28, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 8, 2026 | Mani Sharmaofficer: See Remarks | Purchase | 20 | $160.57 | 19,288 |
| May 20, 2026 | Mani Sharmaofficer: See Remarks | Sale | 11,893 | $185.78 | 19,262 |
House and Senate disclosures
Not reported.